Siehe auch...
EPAS Antikörper
Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|---|
EPAS-1/HIF-2 alpha Antikörper (190b) | sc-13596 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 61 | ||
EPAS-1/HIF-2 alpha Antikörper (A-5) | sc-46691 | mouse IgG2b κ | 556-865 (h) | WB, IP, IF, ELISA | h | 20 |
EPAS CRISPR Knockout, HDR and Double Nickase Plasmids
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
EPAS-1/HIF-2 alpha CRISPR/Cas9 KO Plasmid (h) | sc-400647 | h | Gene Knockout | GFP | 1 | ||
EPAS-1/HIF-2 alpha HDR Plasmid (h) | sc-400647-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
EPAS-1/HIF-2 alpha Double Nickase Plasmid (h) | sc-400647-NIC | h | Gene Knockout | Puromycin | 1 | ||
EPAS-1/HIF-2 alpha Double Nickase Plasmid (h2) | sc-400647-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
EPAS-1/HIF-2 alpha CRISPR/Cas9 KO Plasmid (m2) | sc-420183-KO-2 | m | Gene Knockout | GFP | 0 | ||
EPAS-1/HIF-2 alpha HDR Plasmid (m2) | sc-420183-HDR-2 | m | Homology Directed Repair | Puromycin | 0 | ||
EPAS-1/HIF-2 alpha Double Nickase Plasmid (m) | sc-420183-NIC | m | Gene Knockout | Puromycin | 0 | ||
EPAS-1/HIF-2 alpha Double Nickase Plasmid (m2) | sc-420183-NIC-2 | m | Gene Knockout | Puromycin | 0 |
EPAS CRISPR Activation Products
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
EPAS-1/HIF-2 alpha CRISPR Activation Plasmid (h) | sc-400647-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
EPAS-1/HIF-2 alpha CRISPR Activation Plasmid (h2) | sc-400647-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
EPAS-1/HIF-2 alpha Lentiviral Activation Particles (h) | sc-400647-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
EPAS-1/HIF-2 alpha Lentiviral Activation Particles (h2) | sc-400647-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
EPAS-1/HIF-2 alpha CRISPR Activation Plasmid (m) | sc-420183-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EPAS-1/HIF-2 alpha CRISPR Activation Plasmid (m2) | sc-420183-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EPAS-1/HIF-2 alpha Lentiviral Activation Particles (m) | sc-420183-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
EPAS-1/HIF-2 alpha Lentiviral Activation Particles (m2) | sc-420183-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
EPAS siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
EPAS-1/HIF-2 alpha siRNA (h) | sc-35316 | h | Gene Silencing | N/A | 28 | ||
EPAS-1/HIF-2 alpha shRNA Plasmid (h) | sc-35316-SH | h | Gene Silencing | Puromycin | 28 | ||
EPAS-1/HIF-2 alpha shRNA (h) Lentivirale Partikel | sc-35316-V | h | Gene Silencing | Puromycin | 28 | ||
EPAS-1/HIF-2 alpha siRNA (m) | sc-35317 | m | Gene Silencing | N/A | 3 | ||
EPAS-1/HIF-2 alpha shRNA Plasmid (m) | sc-35317-SH | m | Gene Silencing | Puromycin | 3 | ||
EPAS-1/HIF-2 alpha shRNA (m) Lentivirale Partikel | sc-35317-V | m | Gene Silencing | Puromycin | 3 | ||
EPAS-1/HIF-2 alpha siRNA (r) | sc-270047 | r | Gene Silencing | N/A | 3 | ||
EPAS-1/HIF-2 alpha shRNA Plasmid (r) | sc-270047-SH | r | Gene Silencing | Puromycin | 3 | ||
EPAS-1/HIF-2 alpha shRNA (r) Lentivirale Partikel | sc-270047-V | r | Gene Silencing | Puromycin | 3 |
EPAS Transfected Lysates
Empty Table Header | Produkt | Katnr. | Species | Empfohlener Primärantikörper | Referenzen | Bewertung |
---|---|---|---|---|---|---|
EPAS-1/HIF-2 alpha (m): 293T Lysate | sc-120061 | m | 0 |